1
|
Czarnecki D, Ziółkowski M, Chodkiewicz J, Długosz A, Feldheim J, Waszkiewicz N, Kułak-Bejda A, Gorzkiewicz M, Budzyński J, Junkiert-Czarnecka A, Siomek-Górecka A, Nicpoń K, Kawala-Sterniuk A, Ferri R, Pelc M, Walecki P, Laskowska E, Gorzelańczyk EJ. Initial Study on COMT and DRD2 Gene Polymorphisms as Well as the Influence of Temperament and Character Trait on the Severity of Alcohol Craving in Alcohol-Dependent Patients. J Clin Med 2021; 10:jcm10245892. [PMID: 34945190 PMCID: PMC8704345 DOI: 10.3390/jcm10245892] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/15/2021] [Revised: 12/07/2021] [Accepted: 12/12/2021] [Indexed: 12/31/2022] Open
Abstract
The main aim of this work was to determine the impact of COMT and DRD2 gene polymorphisms together with temperament and character traits on alcohol craving severity alcohol-dependent persons. The sample comprised of 89 men and 16 women (aged 38±7). For the sake of psychological assessment various analytic methods have been applied like the Short Alcohol Dependence Data Questionnaire (SADD), Penn Alcohol Craving Scale (PACS) or Temperament and Character Inventory (TCI) test. The SNP polymorphism of the analyzed genes was determined by Real Time PCR test. The results showed, that the COMT polymorphismmay have an indirected relationship with the intensity and changes in alcohol craving during abstinence. The DRD2 receptor gene polymorphisms are related with the intensity of alcohol craving. It seems that the character traits like “self-targeting”, including “self-acceptance”, are more closely related to the severity of alcohol craving and polymorphic changes in the DRD2 receptor than temperamental traits. Although this is a pilot study the obtained results appeared to be promising and clearly indicate the link betweengene polymorphisms alcohol craving and its severity.
Collapse
Affiliation(s)
- Damian Czarnecki
- Department of Preventive Nursing, Collegium Medicum, Nicolaus Copernicus University, Torun, ul. Ignacego Łukasiewicza 1, 85-821 Bydgoszcz, Poland; (M.Z.); (K.N.)
- Correspondence: (D.C.); (A.K.-S.)
| | - Marcin Ziółkowski
- Department of Preventive Nursing, Collegium Medicum, Nicolaus Copernicus University, Torun, ul. Ignacego Łukasiewicza 1, 85-821 Bydgoszcz, Poland; (M.Z.); (K.N.)
| | - Jan Chodkiewicz
- Institute of Psychology, Department of Clinical Psychology and Psychopathology, University of Lodz, ul. Smugowa 10/12, 91-433 Łódź, Poland;
| | - Anna Długosz
- Faculty of Chemical Technology and Engineering, University of Science and Technology, ul. Seminaryjna 3, 85-326 Bydgoszcz, Poland; (A.D.); (J.F.)
| | - Joanna Feldheim
- Faculty of Chemical Technology and Engineering, University of Science and Technology, ul. Seminaryjna 3, 85-326 Bydgoszcz, Poland; (A.D.); (J.F.)
| | - Napoleon Waszkiewicz
- Department of Psychiatry, Medical University of Białystok, pl. Brodowicza 1, 16-070 Choroszcz, Poland; (N.W.); (A.K.-B.)
| | - Agnieszka Kułak-Bejda
- Department of Psychiatry, Medical University of Białystok, pl. Brodowicza 1, 16-070 Choroszcz, Poland; (N.W.); (A.K.-B.)
| | - Marta Gorzkiewicz
- Department of Molecular Genetics and Justice, Collegium Medicum, Nicolaus Copernicus University, Torun, ul. Marii Skłodowskiej-Curie 9, 85-094 Bydgoszcz, Poland;
| | - Jacek Budzyński
- Department of Vascular and Internal Diseases, Nicolaus Copernicus University, Torun, ul. Ujejskiego 75, 85-168 Bydgoszcz, Poland;
| | - Anna Junkiert-Czarnecka
- Department of Clinical Genetics, Nicolaus Copernicus University, Torun, ul. Marii Skłodowskiej-Curie 9, 85-094 Bydgoszcz, Poland;
| | - Agnieszka Siomek-Górecka
- Department of Clinical Biochemistry, Collegium Medicum, Nicolaus Copernicus University, Torun, ul. Karłowicza 24, 85-092 Bydgoszcz, Poland;
| | - Krzysztof Nicpoń
- Department of Preventive Nursing, Collegium Medicum, Nicolaus Copernicus University, Torun, ul. Ignacego Łukasiewicza 1, 85-821 Bydgoszcz, Poland; (M.Z.); (K.N.)
| | - Aleksandra Kawala-Sterniuk
- Faculty of Electrical Engineering, Automatic Control and Informatics, Opole University of Technology, ul. Prószkowska 76, 45-758 Opole, Poland;
- Correspondence: (D.C.); (A.K.-S.)
| | - Raffaele Ferri
- Oasi Research Institute IRCCS, Via C. Ruggero, 73, 94018 Troina, Italy;
| | - Mariusz Pelc
- Faculty of Electrical Engineering, Automatic Control and Informatics, Opole University of Technology, ul. Prószkowska 76, 45-758 Opole, Poland;
- School of Computing and Mathematical Sciences, University of Greenwich, London SE10 9LS, UK
| | - Piotr Walecki
- Department of Bioinformatics and Telemedicine, Collegium Medicum, Jagiellonian University, ul. Medyczna 7, 30-688 Krakow, Poland;
| | - Ewa Laskowska
- Faculty of Medicine, Collegium Medicum, Nicolaus Copernicus University, Torun, ul. Jagiellońska 15, 85-067 Bydgoszcz, Poland;
| | - Edward Jacek Gorzelańczyk
- Department of Theoretical Basis of BioMedical Sciences and Medical Informatics, Collegium Medicum, Nicolaus Copernicus University, ul. Jagiellońska 15, 85-067 Bydgoszcz, Poland;
- Institute of Philosophy, Kazimierz Wielki University, ul. Ogińskiego 16, 85-092 Bydgoszcz, Poland
- Babinski Specialist Psychiatric Healthcare Center, Outpatient Addiction Treatment, ul. Aleksandrowska 159, 91-229 Łódź, Poland
- The Society for the Substitution Treatment of Addiction “Medically Assisted Recovery”, ul. Rzeźniackiego 1D, 85-791 Bydgoszcz, Poland
| |
Collapse
|
2
|
Sun Z, Ma Y, Xie L, Huang J, Duan S, Guo R, Xie Y, Lv J, Lin Z, Ma S. Behavioral Changes and Neuronal Damage in Rhesus Monkeys after 10 Weeks of Ketamine Administration Involve Prefrontal Cortex Dopamine D2 Receptor and Dopamine Transporter. Neuroscience 2019; 415:97-106. [PMID: 31330230 DOI: 10.1016/j.neuroscience.2019.07.022] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2019] [Revised: 07/01/2019] [Accepted: 07/11/2019] [Indexed: 02/05/2023]
Abstract
The dopamine D2 receptor (DRD2) and dopamine transporter (DAT) play a regulatory role in dopaminergic neurotransmission and thus play an important role in drug addiction. The prefrontal cortex (PFC), a critical part of the mesencephalic dopaminergic system, is thought to be involved in the development and maintenance of drug addiction. The addiction to ketamine is thought to induce behavioral effects primarily through actions on the central nervous system. However, the neural mechanism underlying the effects of ketamine addiction remains unclear. In this study, we investigate the involvement of PFC DRD2 and DAT in ketamine addiction effects after ketamine administration for 10 weeks in nonhuman primates. To this end, after administering ketamine to rhesus monkeys for 10 weeks, we assessed changes in body weight and behavior. Additionally, neuronal changes in the PFC were examined by hematoxylin and eosin (HE) staining; the DRD2 and DAT mRNA and protein expression levels in the PFC were determined by real-time PCR and Western blot analysis, respectively. After 10-week ketamine administration, the assessment of the manifestations of toxicity in rhesus monkeys revealed significant changes in body weight and behavior, decreased DRD2 and DAT mRNA and protein expression in the PFC, and histological abnormalities including neuronal eosinophilia, pyknosis and disorderly arrangement of neurons in the PFC. These results suggest that the reduced expression of DRD2 and DAT in PFC could be involved in the behavioral and the neurological changes induced by ketamine administration, which may play an important role in the molecular mechanisms of ketamine addiction.
Collapse
Affiliation(s)
- Zongbo Sun
- Department of Radiology, The First Affiliated Hospital of Shantou University Medical College, No. 57 Changping Road, Shantou 515041, Guangdong, China; Shantou University Medical College, No. 22 Xinling Road, Shantou, Guangdong 515041, China; Guangdong Key Laboratory of Medical Molecular Imaging, No. 57 Changping Road, Shantou, Guangdong 515041, China
| | - Ye Ma
- Department of Linguistics & Languages, Michigan State University, East Lansing, Michigan MI48824, USA
| | - Lei Xie
- Department of Radiology, The First Affiliated Hospital of Shantou University Medical College, No. 57 Changping Road, Shantou 515041, Guangdong, China; Shantou University Medical College, No. 22 Xinling Road, Shantou, Guangdong 515041, China; Guangdong Key Laboratory of Medical Molecular Imaging, No. 57 Changping Road, Shantou, Guangdong 515041, China
| | - Jinzhuang Huang
- Department of Radiology, The First Affiliated Hospital of Shantou University Medical College, No. 57 Changping Road, Shantou 515041, Guangdong, China; Shantou University Medical College, No. 22 Xinling Road, Shantou, Guangdong 515041, China; Guangdong Key Laboratory of Medical Molecular Imaging, No. 57 Changping Road, Shantou, Guangdong 515041, China
| | - Shouxing Duan
- Shantou University Medical College, No. 22 Xinling Road, Shantou, Guangdong 515041, China; Guangdong Key Laboratory of Medical Molecular Imaging, No. 57 Changping Road, Shantou, Guangdong 515041, China; Department of Pediatric Surgery, The First Affiliated Hospital of Shantou University Medical College, No. 57 Changping Road, Shantou, Guangdong 515041, China
| | - Ruiwei Guo
- Department of Radiology, The First Affiliated Hospital of Shantou University Medical College, No. 57 Changping Road, Shantou 515041, Guangdong, China; Shantou University Medical College, No. 22 Xinling Road, Shantou, Guangdong 515041, China; Guangdong Key Laboratory of Medical Molecular Imaging, No. 57 Changping Road, Shantou, Guangdong 515041, China
| | - Yao Xie
- Department of Radiology, The First Affiliated Hospital of Shantou University Medical College, No. 57 Changping Road, Shantou 515041, Guangdong, China; Shantou University Medical College, No. 22 Xinling Road, Shantou, Guangdong 515041, China; Guangdong Key Laboratory of Medical Molecular Imaging, No. 57 Changping Road, Shantou, Guangdong 515041, China
| | - Junyao Lv
- Department of Forensic Medicine, Shantou University Medical College, No. 22 Xinling Road, Shantou, Guangdong 515041, China
| | - Zhirong Lin
- Department of Radiology, The First Affiliated Hospital of Shantou University Medical College, No. 57 Changping Road, Shantou 515041, Guangdong, China; Guangdong Key Laboratory of Medical Molecular Imaging, No. 57 Changping Road, Shantou, Guangdong 515041, China
| | - Shuhua Ma
- Department of Radiology, The First Affiliated Hospital of Shantou University Medical College, No. 57 Changping Road, Shantou 515041, Guangdong, China; Shantou University Medical College, No. 22 Xinling Road, Shantou, Guangdong 515041, China; Guangdong Key Laboratory of Medical Molecular Imaging, No. 57 Changping Road, Shantou, Guangdong 515041, China.
| |
Collapse
|
3
|
Association between DRD2/ANKK1 TaqIA polymorphism and common illicit drug dependence: evidence from a meta-analysis. Hum Immunol 2014; 76:42-51. [PMID: 25500252 DOI: 10.1016/j.humimm.2014.12.005] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2013] [Revised: 04/27/2014] [Accepted: 12/03/2014] [Indexed: 11/24/2022]
Abstract
BACKGROUND Growing evidence indicated conflicting results about the dopamine receptor D2 (DRD2)/kinase domain containing 1 gene (ANKK1) TaqIA single nucleotide polymorphism (rs1800497) and common illicit drug dependence risk including stimulants, opioid and marijuana. We conducted a meta-analysis to evaluate the association between the polymorphism and common illicit drug dependence risk. METHOD A total of 25 available studies (26 subgroups) testing the association between the polymorphism and common illicit drug dependence were examined through Oct 2013. Pooled odds ratios (ORs) and 95% confidence intervals (CI) were estimated using fixed- and random-effects models when appropriate. Heterogeneity and publication bias were evaluated. RESULTS We found the DRD2/ANKK1 TaqIA polymorphism was significantly associated with increased risk of opioid dependence under homozygote, dominant, and recessive genetic model, respectively (homozygote: OR=1.546, 95%CI=1.279-1.87; dominant: OR=1.265, 95%CI=1.055-1.516; recessive: OR=1.409, 95%CI=1.182-1.680). Subgroup analyses were similar to the results of the total population by ethnicity and quality score. Besides, we also found that Caucasian and low-quality studies were major sources of heterogeneity for opioid dependence. We failed to find any significant association between the polymorphism and stimulants or marijuana neither in total population nor subgroup analyses under any genetic model. CONCLUSIONS The current meta-analysis suggested that DRD2/ANKK1 TaqIA polymorphism might be associated with opioid dependence risk, but not associated with stimulants or marijuana dependence.
Collapse
|
4
|
Abstract
This paper is the thirty-sixth consecutive installment of the annual review of research concerning the endogenous opioid system. It summarizes papers published during 2013 that studied the behavioral effects of molecular, pharmacological and genetic manipulation of opioid peptides, opioid receptors, opioid agonists and opioid antagonists. The particular topics that continue to be covered include the molecular-biochemical effects and neurochemical localization studies of endogenous opioids and their receptors related to behavior, and the roles of these opioid peptides and receptors in pain and analgesia; stress and social status; tolerance and dependence; learning and memory; eating and drinking; alcohol and drugs of abuse; sexual activity and hormones, pregnancy, development and endocrinology; mental illness and mood; seizures and neurologic disorders; electrical-related activity and neurophysiology; general activity and locomotion; gastrointestinal, renal and hepatic functions; cardiovascular responses; respiration and thermoregulation; and immunological responses.
Collapse
Affiliation(s)
- Richard J Bodnar
- Department of Psychology and Neuropsychology Doctoral Sub-Program, Queens College, City University of New York, Flushing, NY 11367, United States.
| |
Collapse
|